ResMed Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| RMD | KMTS | ISRG | MMSI | MMED | TFX | |
|---|---|---|---|---|---|---|
| Market cap | 32.99B | 1.60B | 151.08B | 5.36B | 5.29B | 5.33B |
| P/E (TTM) | 22.5 | — | 49.0 | 36.9 | — | — |
| Forward P/E | 17.7 | -13.1 | 35.3 | 19.5 | 29.5 | 11.5 |
| Price/book | 5.1 | 7.2 | 8.3 | 3.2 | 1.5 | 1.8 |
| Dividend yield | 1.15% | — | — | — | — | 1.09% |
| 1-year change | −15.74% | +19.49% | −2.01% | +9.79% | +6.60% | +4.19% |
| Today | +1.98% | −0.26% | +0.87% | +2.91% | −4.62% | +0.46% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.
Latest news
All RMD news ›Buy, hold, sell: Resmed, Megaport, ANZ shares
Let's start the week with some fresh ratings from the experts. S&P/ASX 200 Index (ASX: XJO) shares rose 0.4% last week and are down almost 2% over 12 months. Let's start the new week with some fresh ratings from the experts (courtesy The…
Is ResMed Facing Fresh Questions Before Results (ASX:RMD)?
ASX Rallies as Banks and BHP Shine, Telcos Slide on SpaceX Fear The company confirmed at the start of the month that it will release its first-quarter fiscal results at the end of October. The release will be the first full set of numbers…
EBITDA of ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh – HAN:RMEA
ResMed, Inc. engages in the design, manufacture, and marketing of equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, as well as the provision of software solutions for residential care…
ResMed (NYSE:RMD) CEO Sells $1,129,613.03 in Stock
Posted by Defense World Staff on Oct 11th, 2026 Read Our Latest Stock Report on RMD ResMed Inc (NYSE: RMD) develops, manufactures and distributes medical equipment and digital health solutions for sleep apnea, chronic obstructive pulmonary…
ResMed Chairman and CEO Michael Farrell Sells 4,991 Shares on 7 October 2026
Kalkine ResMed Inc (ASX:RMD) Chairman and Chief Executive Officer Michael J Farrell exercised stock options and sold 4,991 shares of ResMed common stock on 7 October 2026, according to a Form 4 filing submitted to the United States…
Why Is ResMed (ASX:RMD) Leaning on Capital Returns?
Is Light & Wonder (ASX:LNW) Winning Floor Space After Vegas? Can Catapult Sports (ASX:CAT) Rebuild Momentum After Its Slide? Can WebBeds Group (ASX:WEB) Keep Growing as Shares Lag? Will Tyro Payments (ASX:TYR) Gain From the Surcharge Ban?…
High Flow Nasal Cannula (HFNC) Market Is Going to Boom |• Fisher & Paykel Healthcare • Philips Healthcare • ResMed
Worldwide Market Reports has published its latest research study on the Global High Flow Nasal Cannula HFNC Market offering an extensive evaluation of the industry from 2026 to 2033 The report presents valuable insights into market size…
ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings?
ResMed currently trades at $218.94 per share and has shown little upside over the past six months, posting a small loss of 2.7%. The stock also fell short of the S&P 500’s 15.9% gain during that period. Is now the time to buy RMD? Or does…
RES Continues Treasury Buyback as It Deepens Position in Circular Economy
The latest announcement is out from Recupero Etico Sostenibile S.p.A ( (IT:RES) ). The most recent analyst rating on (IT:RES) stock is a Buy with a EUR12.00 price target. To see the full list of analyst forecasts on Recupero Etico…
Brainsway (NASDAQ:BWAY) & ResMed (NYSE:RMD) Head-To-Head Review
Posted by Danessa Lincoln on Oct 5th, 2026 Brainsway (NASDAQ:BWAY – Get Free Report) and ResMed (NYSE:RMD – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
kalkinemedia.com6
-
tradingview.com5
-
marketbeat.com2
-
openpr.com2
-
themarketsdaily.com2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 31 articles, not a forecast.